TAG
ADPKD
Exaluren trial cleared for rare kidney disease study
Rajiv -
Exaluren has FDA IND clearance for nonsense-mutation ADPKD, opening US sites for the EXPRESS Phase 2 trial of about 60 patients from Q3 2027.


